Cargando…

Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN

Detalles Bibliográficos
Autores principales: Stegelmann, Frank, Wille, Kai, Busen, Hannah, Fuchs, Christiane, Schauer, Stefanie, Sadjadian, Parvis, Becker, Tatjana, Kolatzki, Vera, Döhner, Hartmut, Stadler, Rudolf, Döhner, Konstanze, Griesshammer, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632683/
https://www.ncbi.nlm.nih.gov/pubmed/34785798
http://dx.doi.org/10.1038/s41375-021-01366-3
_version_ 1784607797079441408
author Stegelmann, Frank
Wille, Kai
Busen, Hannah
Fuchs, Christiane
Schauer, Stefanie
Sadjadian, Parvis
Becker, Tatjana
Kolatzki, Vera
Döhner, Hartmut
Stadler, Rudolf
Döhner, Konstanze
Griesshammer, Martin
author_facet Stegelmann, Frank
Wille, Kai
Busen, Hannah
Fuchs, Christiane
Schauer, Stefanie
Sadjadian, Parvis
Becker, Tatjana
Kolatzki, Vera
Döhner, Hartmut
Stadler, Rudolf
Döhner, Konstanze
Griesshammer, Martin
author_sort Stegelmann, Frank
collection PubMed
description
format Online
Article
Text
id pubmed-8632683
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-86326832021-12-15 Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN Stegelmann, Frank Wille, Kai Busen, Hannah Fuchs, Christiane Schauer, Stefanie Sadjadian, Parvis Becker, Tatjana Kolatzki, Vera Döhner, Hartmut Stadler, Rudolf Döhner, Konstanze Griesshammer, Martin Leukemia Correction Nature Publishing Group UK 2021-11-16 2021 /pmc/articles/PMC8632683/ /pubmed/34785798 http://dx.doi.org/10.1038/s41375-021-01366-3 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Stegelmann, Frank
Wille, Kai
Busen, Hannah
Fuchs, Christiane
Schauer, Stefanie
Sadjadian, Parvis
Becker, Tatjana
Kolatzki, Vera
Döhner, Hartmut
Stadler, Rudolf
Döhner, Konstanze
Griesshammer, Martin
Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
title Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
title_full Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
title_fullStr Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
title_full_unstemmed Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
title_short Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
title_sort publisher correction: significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in bcr-abl1-negative myeloproliferative neoplasms (mpn) - on behalf of the german study group-mpn
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632683/
https://www.ncbi.nlm.nih.gov/pubmed/34785798
http://dx.doi.org/10.1038/s41375-021-01366-3
work_keys_str_mv AT stegelmannfrank publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT willekai publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT busenhannah publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT fuchschristiane publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT schauerstefanie publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT sadjadianparvis publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT beckertatjana publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT kolatzkivera publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT dohnerhartmut publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT stadlerrudolf publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT dohnerkonstanze publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn
AT griesshammermartin publishercorrectionsignificantassociationofcutaneousadverseeventswithhydroxyurearesultsfromaprospectivenoninterventionalstudyinbcrabl1negativemyeloproliferativeneoplasmsmpnonbehalfofthegermanstudygroupmpn